General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

Karuna Therapeutics ×

Karuna Therapeutics is a clinical-stage biotechnology company developing a novel oral drug for schizophrenia and Alzheimer's Disease related psychosis.

  • Sector: Life Sciences
  • Headquarters: Boston, Massachusetts
  • Date Invested: 08/10/2022
  • Visit Website